Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy-Reference-Cited by-同舟云学术

Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy

Published:2018-02-20 Issue:7 Volume:50 Page:522-530
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Wang Meng-Lan¹,Liao Juan¹,Wei Bing²,Zhang Dong-Mei¹,He Ming¹,Tao Ming-Chuan²,Chen En-Qiang¹,Tang Hong¹

Affiliation:

1. Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China;

2. Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, PR China

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2018.1442018

Reference28 articles.

1. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity

2. Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia

3. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

4. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis

5. Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critique and systematic review of the clinical utility of hepatitis B core-related antigen;Journal of Hepatology;2023-04

2. Hepatitis B Vaccines;Plotkin's Vaccines;2023

3. Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection;Journal of Antimicrobial Chemotherapy;2022-01-18

4. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment;Virology Journal;2021-01-06

5. Biomarkers for hepatitis B virus replication: an overview and a look to the future;Expert Review of Gastroenterology & Hepatology;2020-09-17